Cardiac REgistry of Celution Device for the Processing of Adipose-derived Regenerative Cells
NCT02735993 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2016-04-13
Summary
This cardiac registry study will collect information from patients with ischemic or non-ischemic heart failure that have been treated with adipose-derived regenerative cells (ADRCs) delivered via intramyocardial injection.
Conditions
Sponsors & Collaborators
-
Cytori Therapeutics
lead INDUSTRY
Principal Investigators
-
Steven Kesten · Cytori Therapeutics
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2016-12-31
- Completion
- 2020-03-31
More Related Trials
-
Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC)
NCT02293603 ·Status: UNKNOWN ·Phase: PHASE1
-
Autologous Cell Therapy for Ischemic Heart Failure
NCT01353690 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Stem Cells Therapy in Advanced Heart Failure
NCT02871466 ·Status: UNKNOWN ·Phase: PHASE4
-
Stem Cell Study for Subjects With Congestive Heart Failure
NCT00620048 ·Status: TERMINATED ·Phase: PHASE1
-
CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction
NCT00893360 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Adipose Derived Stem Cells for Non-Ischemic Congestive Heart Failure
NCT01502501 ·Status: WITHDRAWN ·Phase: NA
-
Stem Cells and Resynchronization Cardiac
NCT00800657 ·Status: UNKNOWN ·Phase: PHASE1
-
Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure
NCT00383630 ·Status: TERMINATED ·Phase: PHASE2
-
Stem Cell Mobilization and VEGF Gene Transfer for Heart Failure
NCT00279539 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety and Efficacy of Adipose Derived Regenerative Cells (ADRCs) Delivered Via the Intracoronary Route in the Treatment of Patients With ST-elevation Acute Myocardial Infarction (AMI)
NCT01216995 ·Status: COMPLETED ·Phase: PHASE2
-
CardiAMP™ Cell Therapy for Heart Failure Trial
NCT02438306 ·Status: COMPLETED ·Phase: PHASE3
-
CD133+ Cell Therapy for Refractory Coronary Heart Disease
NCT01049867 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Randomized Clinical Trial of Adipose-derived Stem Cells in Treatment of Non Revascularizable Ischemic Myocardium
NCT00426868 ·Status: COMPLETED ·Phase: PHASE1
-
Stem Cell Injection to Treat Heart Damage During Open Heart Surgery
NCT01557543 ·Status: TERMINATED ·Phase: PHASE1
-
Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF)
NCT00203203 ·Status: COMPLETED ·Phase: PHASE1
-
Harvest, Isolation and Culture of Cardiac Stem Cells From Endomyocardial Biopsies
NCT01576757 ·Status: WITHDRAWN
-
Autologous Atrial Appendage Derived Cells in the Treatment of Heart Failure
NCT02672163 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Evaluation of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With AMI
NCT02439398 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device Placement
NCT00869024 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intra-coronary Versus Intramyocardial Application of Enriched CD133pos Autologous Bone Marrow Derived Stem Cells
NCT01337011 ·Status: TERMINATED ·Phase: NA
-
Intracoronary Infusion of Autologous Bone Marrow Cells for Treatment of Idiopathic Dilated Cardiomyopathy
NCT00629096 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess Safety & Effects of Autologous ADSCs During Recovery Phase of ST-Elevation MI Effects of Autologous ADSC Implantation During Subacute Recovery Phase of ST-Elevation Myocardial Infarction
NCT03272191 ·Status: WITHDRAWN ·Phase: NA
-
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease
NCT05147766 ·Status: TERMINATED ·Phase: PHASE1
-
Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure
NCT00462774 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy
NCT01020968 ·Status: COMPLETED ·Phase: PHASE2